GGrantIndex
Sort

23,748 grants matching melanoma

Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma

$681,149
Levi Alexander Garraway · Massachusetts General Hospital · P01 · FY2013 · CA

Therapeutic targeting of RNA splicing catalysis through inhibition of Protein Arginine Methylation

$681,123
Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA

Cancer Resistant Mice

$680,577
Bruce A Beutler · Ut Southwestern Medical Center · R01 · FY2025 · CA

Cancer Resistant Mice

$680,577
Bruce A Beutler · Ut Southwestern Medical Center · R01 · FY2022 · CA

MOUSE MODEL OF MALIGNANT MELANOMA

$680,432
Dana-Farber Cancer Institute · U01 · FY2001 · CA

Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity

$680,292
Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA

Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)

$680,004
Isabella Claudia Glitza · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA

Developing new immunotherapies based of CD4 T cells

$679,738
Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

The Nodal Signaling Pathway In Embryonic Development

$679,733
Michael Kuehn · Basic Sciences · Z01 · FY2007 · CA

Evaluating Pathways Involved in Melanoma Initiation

$679,604
Leonard I Zon · Boston Children'S Hospital · R01 · FY2025 · CA

Evolution of Primary and Resistant Solid Tumors

$679,466
Dana-Farber Cancer Institute · U01 · FY2004 · CA

NOVEL APPROACHES TO ANTITUMOR DRUG DESIGN

$679,290
University Of Arizona · R35 · FY2000 · CA

Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade

$678,954
Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2019 · CA

Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy

$678,605
Weizhou Zhang · University Of Florida · R01 · FY2024 · CA

Ultrasonic perfusion imaging of peripheral vascular disease

$678,480
Michael F Insana · University Of Illinois At Urbana-Champaign · R01 · FY2021 · HL

Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma

$678,399
Carrie Daniel-Macdougall · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

Reducing Errors in the Diagnosis of Melanoma and Melanocytic Lesions

$678,146
Joann G Elmore · University Of California Los Angeles · R01 · FY2018 · CA

MYELOID-DERIVED SUPPRESSOR CELLS IN CHECKPOINT PROTEIN INHIBITION FOR MELANOMA

$677,999
New York University · · FY2016 · Department of Defense

Tumor gene expression in vitro and in vivo

$677,938
Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Adoptive Transfer of MART-1 TCR Engineered Cells after a Myelodepleting Regimen

$677,575
Antoni Ribas · California Institute Of Technology · P01 · FY2011 · CA

TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors

$677,410
Craig M. Brackett · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA

Tumor Microenvironment in Cancer Progression

$676,757
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Infections, immunity, and inflammation in cancer

$676,674
Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA

A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations

$676,657
Christine Veenstra · University Of Michigan At Ann Arbor · R37 · FY2021 · CA

Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma

$676,478
Carrie Daniel-Macdougall · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA